Gaudi Clinical
Latest round
- Series A
Last raised
- Feb 2025
Total raised
- $11M
Investors
- 8
About Gaudi Clinical
Founded in 2021 and based in Tokyo, Japan, Gaudi Clinical operates as a producer of cultivated cells used in regenerative medicine for the dentistry and orthopedic fields. Gaudi Clinical specializes in advanced regenerative medicine solutions, focusing on autologous PRP (Platelet-Rich Plasma) therapies and Adult Stem Cells (ASCs). These treatments are aimed at enhancing healing processes in surgical environments and improving patient outcomes, catering to healthcare providers, hospitals, and research institutions both in Japan and potentially in other Asian markets. Their products are presented at key industry conferences, highlighting their commitment to medical innovation. Gaudi Clinical operates on a B2B model, engaging healthcare institutions and professionals in the procurement of their regenerative medicine products. Revenue is generated through transactions for individual therapies and potential subscriptions within medical networks, facilitating ongoing support for their offerings.
Who invested in Gaudi Clinical
8 investors across 2 rounds
See all investors in Gaudi Clinical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gaudi Clinical
Who invested in Gaudi Clinical?
Gaudi Clinical has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gaudi Clinical raised?
Gaudi Clinical has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Gaudi Clinical last raise money?
Gaudi Clinical's most recent round on record is a Series A, in Feb 2025.
What does Gaudi Clinical do?
Founded in 2021 and based in Tokyo, Japan, Gaudi Clinical operates as a producer of cultivated cells used in regenerative medicine for the dentistry and orthopedic fields.
Where is Gaudi Clinical headquartered?
Gaudi Clinical is headquartered in Tokyo, Japan.
Which VCs invest in companies like Gaudi Clinical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Gaudi Clinical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Gaudi Clinical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.